CTRI/2010/091/002818已完成未知
A molecular ePIdemiOlogy study in Asia patients with advanced NSCLC of adEno histology to assess EGFR mutation status (PIONEER)
AstraZeneca,Singapore Pte LtdAsia0 个研究点目标入组 1,279 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,279
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Provision of written informed consent
- •- Patients age 20 years or older
- •- Histological or cytological confirmed advanced (stage IIIb/IV) NSCLC of adenohistology
- •- NSCLC treatment naïve
- •- Provision of cancer tissue or cytology sample (surgical specimen, biopsy sample, or cytology sample is acceptable).
排除标准
- •- Involvement in the planning and/or conduct of the study (applies to both
- •AstraZeneca staff and/or staff at the study site)
- •- Previous enrolment in the present study
研究者
相似试验
招募中
不适用
Molecular pathological epidemiology research on pancreatic tumorsPancreatic tumorsJPRN-UMIN000044027Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo2,000
尚未招募
不适用
Multicenter registry study of Japanese patients with inflammatory bowel disease with COVID-19inflammatory bowel disease COVID-19JPRN-UMIN000040656Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine200
招募中
不适用
ation-wide epidemiological study of patients with HTLV-1-associated myelopathy (HAM/TSP)HTLV-1-Associated-Myelopathy Tropical Spastic Paraparesis (HAM/TSP)JPRN-UMIN000028400St. Marianna University School of Medicine1,000
招募中
不适用
Study about clinical characteristics and molecular markers of carcinosarcoma of the uterusNL-OMON51322Erasmus MC, Universitair Medisch Centrum Rotterdam30
已完成
不适用
Japanese research for patients with non-metastatic castration resistant prostate cancer - enzalutamideon-metastatic castration resistant prostate cancerJPRN-UMIN000018964Kagawa University Faculty of Medicine60